Although CRP is a reliable marker of inflammation, several other inflammatory mediators are critically involved in the pathogenesis of CAD and may serve as potential biomarkers providing additional prognostic information, i.e. monocyte chemoattractant protein-1 (MCP-1) [3, 4]. Here, CRP is linked to coronary artery disorder.